Remdesivir Decreases Mortality in COVID-19 Patients with Active Malignancy

SIMPLE SUMMARY: Patients with active malignancies have an increased risk for severe SARS-CoV-2 infection and high mortality from COVID-19. Additionally, due to the underlying immune deficiency, prolonged replication and a higher rate of escape mutations are seen. Thus, it is crucial to introduce dir...

Descripción completa

Detalles Bibliográficos
Autores principales: Jaroszewicz, Jerzy, Kowalska, Justyna, Pawłowska, Małgorzata, Rogalska, Magdalena, Zarębska-Michaluk, Dorota, Rorat, Marta, Lorenc, Beata, Czupryna, Piotr, Sikorska, Katarzyna, Piekarska, Anna, Dworzańska, Anna, Zaleska, Izabela, Mazur, Włodzimierz, Kozielewicz, Dorota, Kłos, Krzysztof, Podlasin, Regina, Angielski, Grzegorz, Oczko-Grzesik, Barbara, Figlerowicz, Magdalena, Szetela, Bartosz, Bolewska, Beata, Frańczak-Chmura, Paulina, Flisiak, Robert, Tomasiewicz, Krzysztof
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563758/
https://www.ncbi.nlm.nih.gov/pubmed/36230641
http://dx.doi.org/10.3390/cancers14194720

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563758/
https://www.ncbi.nlm.nih.gov/pubmed/36230641
http://dx.doi.org/10.3390/cancers14194720

Ejemplares similares